Clin2
NCT06181513Likely a fitRecruiting

Probiotics for mild Alzheimer's disease

Neurodegenerative DiseasesCognition Disorders in Old Age

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
40 people
Ages
65 years to 85 years
Study type
Interventional

Who can take part

  • You are 65 years or older
  • You have been diagnosed with mild Alzheimer's disease (MMSE score 19-23)
  • You have not taken antibiotics in the last 6 months
  • You have not taken probiotics in the last 6 months
  • You do not have other serious health conditions (like neurological disease, major depression, gastrointestinal disease, or heart disease)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07062198Recruiting· Phase 3
Metabolic supplement for Alzheimer's disease

This trial tests a special supplement combination designed to support brain energy use in people with Alzheimer's. It aims to see if the supplement can help slow cognitive decline.

Alanya
NCT07496021Recruiting
Probiotic for early Alzheimer's: safety and memory benefits

This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.

Gyeonggi-do
NCT06670807Recruiting
Probiotic supplement for mild memory loss

This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.

Madrid, Madrid
NCT06278688Not yet recruiting
Probiotic supplement for mild cognitive impairment

This study tests whether a precision probiotic supplement can help people with mild cognitive impairment (MCI) who also have signs of amyloid buildup in the brain. If you qualify, you would be randomly assigned to take the probiotic or a placebo for a period of time.

NCT07413744Not yet recruiting· Phase 2
Gut health and probiotics study for memory concerns

This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.

Madison, Wisconsin
NCT07226674Recruiting
Study of gut health and plant nutrients for brain health

This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.

Coleraine

Hear when a new Neurodegenerative Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.